Polysaccharides from Phellinus linteus attenuate type 2 diabetes mellitus in rats via modulation of gut microbiota and bile acid metabolism

被引:22
作者
Liu, Tingting [1 ]
Zhao, Min [1 ]
Zhang, Yumeng [1 ]
Xu, Ruixiang [1 ]
Fu, Zixuan [1 ]
Jin, Tong [1 ]
Song, Jiaxi [2 ]
Huang, Yihe [3 ]
Wang, Miao [2 ,4 ]
Zhao, Chunjie [1 ,5 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Wenhua Rd 103, Shenyang, Liaoning, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Wenhua Rd 103, Shenyang, Liaoning, Peoples R China
[3] Shenyang Med Coll, Sch Publ Hlth, Huanghe North St 146, Shenyang, Liaoning, Peoples R China
[4] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China
[5] Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Phellinus linteus polysaccharides; Type 2 diabetes mellitus; Gut microbiota; INSULIN-RESISTANCE; PEPTIDE-1; SECRETION; MECHANISMS; INFLAMMATION; RECEPTORS; BACTERIA; OBESITY;
D O I
10.1016/j.ijbiomac.2024.130062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is the most prevalent metabolic disorder. Polysaccharides from Phellinus linteus (PLP) have been found to have anti-diabetes effects, but the mechanism has not been elucidated. The purpose of this study was to investigate the mechanism of PLP on T2DM through the gut microbiota and bile acids metabolism. The T2DM rat model was induced by a high-fat high-carbohydrate (HFHC) diet and streptozocin (30 mg/ kg). We found that PLP ameliorated diabetes symptoms. Besides, PLP intervention increased the abundance of g_Bacteroides, g_Parabacteroides, and g_Alistioes, which are associated with the biosynthesis of short-chain fatty acids (SCFAs) and bile acids (BAs) metabolism. Meanwhile, untargeted and targeted metabolomics indicated that PLP could regulate the composition of BAs and increase the levels of SCFAs. Real-time quantitative PCR (RTqPCR) and enzyme-linked immunosorbent assay (ELISA) were performed to analyze the expression levels of BAs metabolism enzymes in the liver. Finally, the results of correlation analysis and Glucagon-like peptide-1 (GLP-1) showed that PLP stimulated the release of GLP-1 by regulating SCFAs and BAs. In conclusion, this study demonstrated that PLP can regulate gut microbiota and BAs metabolism to promote GLP-1 secretion, thereby increasing insulin release, decreasing blood glucose and attenuating T2DM.
引用
收藏
页数:14
相关论文
共 68 条
[21]   Role of gut microbiota in type 2 diabetes pathophysiology [J].
Gurung, Manoj ;
Li, Zhipeng ;
You, Hannah ;
Rodrigues, Richard ;
Jump, Donald B. ;
Morgun, Andrey ;
Shulzhenko, Natalia .
EBIOMEDICINE, 2020, 51
[22]  
Huang SM, 2019, FOOD FUNCT, V10, P3224, DOI [10.1039/C9FO00263D, 10.1039/c9fo00263d]
[23]   Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis [J].
Jia, Wei ;
Xie, Guoxiang ;
Jia, Weiping .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (02) :111-128
[24]   Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome [J].
Jones, Brian V. ;
Begley, Maire ;
Hill, Colin ;
Gahan, Cormac G. M. ;
Marchesi, Julian R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (36) :13580-13585
[25]   Mechanisms linking obesity to insulin resistance and type 2 diabetes [J].
Kahn, Steven E. ;
Hull, Rebecca L. ;
Utzschneider, Kristina M. .
NATURE, 2006, 444 (7121) :840-846
[26]   Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1 [J].
Katsuma, S ;
Hirasawa, A ;
Tsujimoto, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) :386-390
[27]  
Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db15-0518, 10.2337/db14-0716, 10.2337/db15-0518]
[28]   Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients [J].
Li, Guo-Hua ;
Huang, Shi-Jia ;
Li, Xiang ;
Liu, Xiao-Song ;
Du, Qiao-Ling .
WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (46) :7338-7351
[29]   Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction [J].
Li, Jingwei ;
Zhao, Min ;
Li, Jianming ;
Wang, Miao ;
Zhao, Chunjie .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[30]   Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats [J].
Li, Lin ;
Zhong, Sen-jie ;
Hu, Si-yuan ;
Cheng, Bin ;
Qiu, Hong ;
Hu, Zhi-xi .
BMC MICROBIOLOGY, 2021, 21 (01)